Eligibility Prostatic Neoplasms NCT00537381

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed cancer of the prostate
Description

Prostate carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0600139
evidence of metastatic disease
Description

Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0027627
have a life expectancy greater than 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
have at least 4 weeks from previous major surgery to date of first study agent given
Description

Major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
have progressive hormone-refractory disease after orchiectomy or gonadotropin-releasing hormone analog and/or antiandrogen treatment within 6 months prior to the first study agent administration exclusion criteria
Description

Progressive Disease Hormone Refractory | Status post Orchiectomy | Status post Gonadotropin-Releasing Hormone Analog | Status post Antiandrogen therapy | Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C0019932
UMLS CUI [1,3]
C0205269
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0029189
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1518041
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0279492
UMLS CUI [5]
C0680251
have known central nervous system metastases (cancerous tumors that have spread to the brain from somewhere else in the body)
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
had prior systemic non-hormonal therapy for hormone refractory prostate cancer
Description

Systemic therapy Hormone refractory prostate cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1328504
have known human immunodeficiency virus (hiv, a life-threatening infection which you can get from an infected person's blood or from having sex with an infected person) seropositivity or known hepatitis b or c infection
Description

HIV Seropositivity | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
have planned major surgery during the study
Description

Major surgery Planned

Data type

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C1301732
have taken any over-the-counter (medicine that can be bought without a prescription) or herbal treatment for prostate cancer within 4 weeks prior to the first study treatment administration
Description

Non-Prescription Drugs Prostate carcinoma | Herbal therapy Prostate carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0013231
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C0242388
UMLS CUI [2,2]
C0600139

Similar models

Eligibility Prostatic Neoplasms NCT00537381

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma
Item
confirmed cancer of the prostate
boolean
C0600139 (UMLS CUI [1])
Neoplasm Metastasis
Item
evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
Life Expectancy
Item
have a life expectancy greater than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Major surgery
Item
have at least 4 weeks from previous major surgery to date of first study agent given
boolean
C0679637 (UMLS CUI [1])
Progressive Disease Hormone Refractory | Status post Orchiectomy | Status post Gonadotropin-Releasing Hormone Analog | Status post Antiandrogen therapy | Exclusion Criteria
Item
have progressive hormone-refractory disease after orchiectomy or gonadotropin-releasing hormone analog and/or antiandrogen treatment within 6 months prior to the first study agent administration exclusion criteria
boolean
C1335499 (UMLS CUI [1,1])
C0019932 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0029189 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1518041 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0279492 (UMLS CUI [4,2])
C0680251 (UMLS CUI [5])
CNS metastases
Item
have known central nervous system metastases (cancerous tumors that have spread to the brain from somewhere else in the body)
boolean
C0686377 (UMLS CUI [1])
Systemic therapy Hormone refractory prostate cancer
Item
had prior systemic non-hormonal therapy for hormone refractory prostate cancer
boolean
C1515119 (UMLS CUI [1,1])
C1328504 (UMLS CUI [1,2])
HIV Seropositivity | Hepatitis B | Hepatitis C
Item
have known human immunodeficiency virus (hiv, a life-threatening infection which you can get from an infected person's blood or from having sex with an infected person) seropositivity or known hepatitis b or c infection
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Major surgery Planned
Item
have planned major surgery during the study
boolean
C0679637 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Non-Prescription Drugs Prostate carcinoma | Herbal therapy Prostate carcinoma
Item
have taken any over-the-counter (medicine that can be bought without a prescription) or herbal treatment for prostate cancer within 4 weeks prior to the first study treatment administration
boolean
C0013231 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0242388 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])